@article{3098049, title = "Human herpesvirus 8 infection in hemodialysis patients", author = "Zavitsanou, A and Sypsa, V and Petrodaskalaki, M and Psichogiou, M and and Katsoulidou, A and Boletis, J and Hadjiconstantinou, V and Karalis, D and and Kalapothaki, V and Hatzakis, A", journal = "American Journal of Kidney Diseases", year = "2006", volume = "47", number = "1", pages = "167-170", publisher = "W B SAUNDERS CO-ELSEVIER INC", issn = "0272-6386, 1523-6838", doi = "10.1053/j.ajkd.2005.09.019", keywords = "human herpesvirus 8; hemodialysis (HD); cohort; seroconversion; seroreversion", abstract = "Background: The aim of the present study was to evaluate human herpesvirus 8 (HHV-8) seroprevalence in Greek hemodialysis patients. Patterns of change in HHV-8 serostatus (seroconversions and seroreversions) over time were also evaluated. Methods: Serum samples obtained from a cohort of 485 Greek hemodialysis patients were tested for antibodies to HHV-8 by whole virus lysate enzyme-linked immunosorbent assay, and reactive samples were confirmed by means of the orf-73 enzyme-linked immunosorbent assay. HHV-8 seroprevalence at study entry and the incidence of seroreversions and seroconversions per 100 person-years were estimated. Results: The prevalence of HHV-8 antibodies in Greek hemodialysis patients at enrollment was 7.2%. No univariate associations were established between HHV-8 serostatus and patients’ characteristics. Incidences of seroreversions and seroconversions were 16.4/100 person-years (95% confidence interval, 7.1 to 32.3) and 0.28/100 person-years (95% confidence interval, 0.03 to 1.02), respectively. Patients 50 years and younger had an increased probability for seroreversion to HHV-8 antibodies than patients older than 50 years (log-rank test, P = 0.018). Conclusion: We observed a fair number of seroreversions and a low incidence of seroconversion to HHV-8 infection in hemodialysis patients in Greece. Our data provide indirect evidence that HHV-8 transmission in the hemodialysis setting is uncommon." }